The difference and use of tilpotide/mufenda and tilsipotide

Tirzepatide and tilsipotide are often confused in pharmaceutical literature and some informal translations, and are even mistaken by patients as two different drugs. In fact, they refer to the same drug, but there are differences in Chinese translation and transliteration habits. Tilpotide is the commonly used official translation, while tilsipotide is derived from some international transliteration versions or non-unified names in the early research stages. Currently, the globally unified international generic drug name is Tirzepatide, and the trade name is Mounjaro.

In terms of its mechanism of action, compared with traditionalGLP-1 receptor agonists such as Semaglutide, Tilpotide is unique in that it activates both GLP-1 and GIP pathways at the same time, thus showing stronger comprehensive efficacy in improving blood sugar and weight loss. This "dual-target" mechanism makes it stand out among similar drugs and is called "the beginning of a new era of metabolic drugs" by many experts.

In actual use, tilpotide is mostly administered by subcutaneous injection once a week, and the dose can be gradually increased according to the patient's tolerance. There is no pharmacological difference from tisipotide, and the differences are limited to translation and nomenclature. Therefore, if a patient hears "tilsipotide" in different information or doctor's instructions, it can be understood that it is another name for tilpotide, and there is no need to worry about different drugs or differences in efficacy.

It is worth noting that the indications of tilpotide are mainly concentrated in patients with type 2 diabetes and obesity, and some countries or regions have included it in the application exploration of obesity treatment. Compared with traditional antidiabetic drugs such as metformin and SGLT2 inhibitors, tilpotide has particularly outstanding dual advantages in blood sugar control and weight management, which has also led to its rapid rise in market demand worldwide.

Reference materials:https://www.drugs.com/tirzepatide.html